Acetylcysteine 20% nebulising solution for COPD

14.04.2015

ACPHARM was approached by a patient with Chronic Obstructive Pulmonary Disease (COPD) that was suffering from breathing problems who had previously responded positively to Acetylcysteine 20% nebulising solution overseas, but was unable to obtain it in Australia because it is not currently marketed here. The patient had already approached other compounders who were unable or unwilling to do this.

ACPHARM has the specialised pharmacists and equipment to tackle almost any compounding request, and successfully compounded this medication which saw an excellent improvement in the patient’s breathing. Patients often require medications that no longer available, or are in limited supply. By compounding these formulations, ACPHARM is able to provide necessary and often life-saving medications to patients.